Impact of Bone Marrow Aspirate Tregs on the Response Rate of Younger Newly Diagnosed Acute Myeloid Leukemia Patients

Table 3

Bone marrow aspirate T, NK, and B population in diagnosis and after treatment phase.

	Diagnosis	After treatment
CD3+/μL, mean value (mv)	1350	960	0.125^a
CD4+/μL, mv	721	481	0.116^a
CD8+/μL, mv	370	373	0.870^a
Tregs/μL, mv	21	12	0.038^a
CD16+/56+, median value (med v)	225	256	0.742^b
CD19+/μL, med v	265	12	0.008^b

^aPaired -test. ^bWilcoxon signed-rank test. CD16+/56+: NK; CD19+: B cells. Bold values are statistically significant ().